Atlas FDA

ReActiv8 Implantable Neurostimulation System

FDA premarket approval P190021/S008 · decided 2024-12-12

Approval details

PMA number
P190021
Supplement
S008
Supplement type
Special (Immediate Track)
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
ReActiv8 Implantable Neurostimulation System
Generic name
Stimulator, neuromuscular, lower back muscles, totally implanted for pain relief
Applicant
Mainstay Medical Limited
Date received
2024-11-14
Decision date
2024-12-12
Days to decision
28 days
Decision code
APPR
Product code
QLK
Advisory committee
Neurology
Expedited review
No
Location
Swords, Co Dublin
Statement
approval for modifications to labeling related to two separate updates, clarification regarding the allowable receive coils compatible with the system’s Magnetic Resonance (MR) conditional labelling and refinement of the considerations for patient selection

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.